Showing results (41-50 of 172) with videos related to
Sort By:
Pageof 18
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 13, 2020
Stage IVA cervical cancer: outcomes of disease related complications and treatmentBeman Roy Khulpateea, Annette Paulson, Matthew Carlson, et al.Gynecologic Oncology|December 7, 2002
A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group studyDavid Scott Miller, John A Blessing, Samuel S Lentz, et al.Clinical Microbiology Reviews|January 19, 2008
Update on rapid diagnostic testing for malariaClinton K Murray, Robert A Gasser, Alan J Magill, et al.Cancer|October 10, 2003
Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group studyDavid Scott Miller, John A Blessing, Samuel S Lentz, et al.Journal of Drug Targeting|November 10, 2006
Water-soluble HPMA copolymer--prostaglandin E1 conjugates containing a cathepsin K sensitive spacerHuaizhong Pan, Pavla Kopecková, Dong Wang, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 4, 2006
Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in miceVivian R Whitaker, Lin Cui, Scott Miller, et al.Cancers|February 11, 2023
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer TreatmentIgnace Vergote, Teresa Macarulla, Fred R Hirsch, et al.Journal of Consulting and Clinical Psychology|September 24, 2019
Are high-performing therapists both effective and consistent? A test of therapist expertiseJesse Owen, Joanna M Drinane, Martin Kivlighan, et al.The American Journal of Tropical Medicine and Hygiene|December 19, 2006
Sensitivity and specificity of an antigen detection ELISA for malaria diagnosisHarald Noedl, Kritsanai Yingyuen, Anintita Laoboonchai, et al.Gynecologic Oncology|June 25, 2005
Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group studyDavid Scott Miller, John A Blessing, Jeanne Schilder, et al.Pageof 18